Literature DB >> 21070810

Cellular IMPDH enzyme activity is a potential target for the inhibition of Chikungunya virus replication and virus induced apoptosis in cultured mammalian cells.

M Khan1, R Dhanwani, I K Patro, P V L Rao, M M Parida.   

Abstract

Inosine monophosphate dehydrogenase (IMPDH) catalyzes an essential step in the de novo biosynthesis of guanine nucleotide, namely, the conversion of IMP to XMP. The depletion of the intracellular GTP and dGTP pools is the major event occurring in the cells exposed to the inhibitors such as mycophenolic acid. The present study was undertaken with an objective to assess the antiviral potential of mycophenolic acid (MPA) against Chikungunya virus via inhibition of IMPDH enzyme in Vero cells. The inhibitory potential of MPA on CHIKV replication was assessed by virus inhibition assay (cytopathic effect, immunofluorescence), virus yield reduction assay and cell viability assay. Inhibition of virus induced apoptosis was analyzed by Hoechst staining, DNA fragmentation, immunoblotting of Caspase-3, PARP and Bcl-2. Percentage apoptotic cell population was determined by flow cytometry. Total genome infectivity was determined by analyzing the ratio of total infectious viral particles to the genome copy number. Non-toxic concentration of MPA (10 μM) reduced ≥ 99.9% CHIKV titre in Vero cells. MPA via depletion of substrate for polymerase (GTP), inhibited CHIKV induced apoptosis. By limiting the rate of de novo synthesis of guanosine nucleotide, MPA could apparently block the formation of the CHIKV progeny. The antiviral activity of MPA against Chikungunya virus is mediated through depletion of GTP pool via inhibition of IMPDH as demonstrated by Immunoblotting and different microscopic analysis.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21070810     DOI: 10.1016/j.antiviral.2010.10.009

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  38 in total

1.  Mycophenolate mofetil inhibits hepatitis C virus replication in human hepatic cells.

Authors:  Li Ye; Jieliang Li; Ting Zhang; Xu Wang; Yizhong Wang; Yu Zhou; Jinping Liu; Hemant K Parekh; Wenzhe Ho
Journal:  Virus Res       Date:  2012-06-21       Impact factor: 3.303

2.  Oxanosine Monophosphate Is a Covalent Inhibitor of Inosine 5'-Monophosphate Dehydrogenase.

Authors:  Runhan Yu; Youngchang Kim; Natalia Maltseva; Philip Braunstein; Andrzej Joachimiak; Lizbeth Hedstrom
Journal:  Chem Res Toxicol       Date:  2019-02-25       Impact factor: 3.739

Review 3.  Towards antivirals against chikungunya virus.

Authors:  Rana Abdelnabi; Johan Neyts; Leen Delang
Journal:  Antiviral Res       Date:  2015-06-25       Impact factor: 5.970

4.  Beyond Members of the Flaviviridae Family, Sofosbuvir Also Inhibits Chikungunya Virus Replication.

Authors:  André C Ferreira; Patrícia A Reis; Caroline S de Freitas; Carolina Q Sacramento; Lucas Villas Bôas Hoelz; Mônica M Bastos; Mayara Mattos; Natasha Rocha; Isaclaudia Gomes de Azevedo Quintanilha; Carolina da Silva Gouveia Pedrosa; Leticia Rocha Quintino Souza; Erick Correia Loiola; Pablo Trindade; Yasmine Rangel Vieira; Giselle Barbosa-Lima; Hugo C de Castro Faria Neto; Nubia Boechat; Stevens K Rehen; Karin Brüning; Fernando A Bozza; Patrícia T Bozza; Thiago Moreno L Souza
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

5.  Inhibition of chikungunya virus replication by harringtonine, a novel antiviral that suppresses viral protein expression.

Authors:  Parveen Kaur; Meerra Thiruchelvan; Regina Ching Hua Lee; Huixin Chen; Karen Caiyun Chen; Mah Lee Ng; Justin Jang Hann Chu
Journal:  Antimicrob Agents Chemother       Date:  2012-10-22       Impact factor: 5.191

Review 6.  Prophylactic strategies to control chikungunya virus infection.

Authors:  Friederike I L Hucke; Malena Bestehorn-Willmann; Joachim J Bugert
Journal:  Virus Genes       Date:  2021-02-15       Impact factor: 2.332

Review 7.  Drug repurposing approach to combating coronavirus: Potential drugs and drug targets.

Authors:  Jimin Xu; Yu Xue; Richard Zhou; Pei-Yong Shi; Hongmin Li; Jia Zhou
Journal:  Med Res Rev       Date:  2020-12-05       Impact factor: 12.944

8.  Evaluation of cell viability dyes in antiviral assays with RNA viruses that exhibit different cytopathogenic properties.

Authors:  Donald F Smee; Brett L Hurst; W Joseph Evans; Nathan Clyde; Sean Wright; Christopher Peterson; Kie-Hoon Jung; Craig W Day
Journal:  J Virol Methods       Date:  2017-03-27       Impact factor: 2.623

9.  M Segment-Based Minigenome System of Severe Fever with Thrombocytopenia Syndrome Virus as a Tool for Antiviral Drug Screening.

Authors:  Hiroshi Yamada; Satoshi Taniguchi; Masayuki Shimojima; Long Tan; Miyuki Kimura; Yoshitomo Morinaga; Takasuke Fukuhara; Yoshiharu Matsuura; Takashi Komeno; Yousuke Furuta; Masayuki Saijo; Hideki Tani
Journal:  Viruses       Date:  2021-06-03       Impact factor: 5.048

Review 10.  Small Molecule Inhibitors Targeting Chikungunya Virus.

Authors:  Nicole Haese; John Powers; Daniel N Streblow
Journal:  Curr Top Microbiol Immunol       Date:  2022       Impact factor: 4.737

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.